Genes and heart inflammation from immunotherapy
Part of Bones, joints & muscles, Brain & nervous system, Heart & circulation clinical trials.
This study looks at genetic factors that may affect the risk of heart inflammation (myocarditis) caused by immune checkpoint inhibitors (ICIs), a type of cancer immunotherapy. It aims to find out if your genes make you more likely to develop this side effect.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You take an immune checkpoint inhibitor (a type of immunotherapy) for at least 3 months and got at least 2 doses
- You have not developed new heart-related symptoms, ECG changes, or high troponin (a heart enzyme) since starting the drug
- You can sign a consent form and have social security coverage (except AME)
- You are not pregnant or breastfeeding and are not under legal guardianship
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This research tracks outcomes for cancer patients who developed heart inflammation (myocarditis) while receiving immune checkpoint inhibitor therapy. By studying survival patterns, researchers hope to better understand how to manage this serious side effect and improve care for future patients.
This study uses heart scans (MRI or nuclear imaging) to better understand inflammatory heart conditions. If you have a suspected inflammatory heart disease and are already scheduled for one of these scans, you may be able to join.
This study uses artificial intelligence to analyze heart electrical recordings (ECGs) from existing patient databases to better detect dangerous heart rhythm problems and heart inflammation caused by cancer immunotherapy. Researchers are not giving any new treatments—they're studying existing data to improve diagnosis.
This study uses heart MRIs to monitor women with gynecologic cancers who are about to start immunotherapy. The goal is to detect early signs of heart problems so doctors can take action quickly.
This study looks for specific markers in the blood that can help doctors better understand and treat heart inflammation (myocarditis) caused by immunotherapy in people with lung cancer. If you join, you will help find ways to improve care for other patients.
This study looks at how inflammatory diseases (like rheumatoid arthritis or psoriasis) affect heart health. It aims to understand and improve heart disease risk in people with these conditions, whether they have had a heart event or not.
Hear when a new ICI-myocarditis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.